Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HU9H
|
|||
| Former ID |
DAP001009
|
|||
| Drug Name |
Panitumumab
|
|||
| Synonyms |
Vectibix; Panitumumab (genetical recombination); Vectibix (TN); Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN); Panitumumab (EGFR mAb inhibitor)
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Approved | [1], [2] | |
| Head and neck cancer [ICD-11: 2D42] | Phase 2 | [1], [3] | ||
| Therapeutic Class |
Anticancer Agents
|
|||
| Company |
Amgen & Takeda
|
|||
| PubChem Substance ID | ||||
| ADReCS Drug ID | BADD_D01666 | |||
| SuperDrug ATC ID |
L01XC08
|
|||
| Drug Resistance Mutation (DRM) | Top | |||
|---|---|---|---|---|
| DRM | DRM Info | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6883). | |||
| REF 2 | 2006 drug approvals: finding the niche. Nat Rev Drug Discov. 2007 Feb;6(2):99-101. | |||
| REF 3 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (BLA) 125147. | |||
| REF 4 | Integration of panitumumab into the treatment of colorectal cancer. Crit Rev Oncol Hematol. 2010 Apr;74(1):16-26. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.